Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Augmentin Intravenous 600mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) |
| BNF code | 0501013K0BBACAE |
| Virtual Medicinal Product | Co-amoxiclav 500mg/100mg powder for solution for injection vials |
| Name | Augmentin Intravenous 600mg powder for solution for injection vials |
| Abbreviated name | Augmentin Intravenous 600mg inj vials |
| Date of name applicability | 18 May 2004 |
| Previous name | Augmentin Intravenous 600mg injection vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Not available |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.